LIGAND PHARMACEUTICALS INC shareholders Q3 2023

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

LIGAND PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
ISTHMUS PARTNERS, LLC 32,817$1,966,3950.28%
Hillsdale Investment Management Inc. 47,632$2,854,1100.26%
WOODSTOCK CORP 34,160$2,046,8670.26%
Linden Thomas Advisory Services, LLC 16,779$1,005,3980.22%
Spouting Rock Asset Management, LLC 9,219$552,4020.18%
Nebula Research & Development LLC 5,379$322,3100.17%
Intrinsic Edge Capital Management LLC 24,900$1,492,0080.17%
KORNITZER CAPITAL MANAGEMENT INC /KS 135,482$8,118,0810.17%
Virtus ETF Advisers LLC 3,904$233,9280.14%
AMI ASSET MANAGEMENT CORP 33,936$2,033,4410.13%
External links

This page lists LIGAND PHARMACEUTICALS INC's shareholders in Q3 2023. To view LIGAND PHARMACEUTICALS INC's shareholder history, click here.